| Title | Partnership initiative for the Evaluation of technological innovation in Radiotherapy (PERA) |
| Protocole ID | PERA |
| ClinicalTrials.gov ID | NCT03378856 |
| Cancer Type(s) | Other |
| Phase | Other |
| Stage | |
| Study Type | |
| Drug | |
| Institution |
CISSS DE LAVAL
 HOPITAL DE LA CITE-DE-LA-SANTE
1755 boul. René-Laennec, Laval, QC, H7M 3L9 |
| City | Laval |
| Principal Investigator |
Dr. Marie-Andrée Fortin |
| Coordinator |
Solange Tremblay 450-668-1010 poste 23603 |
| Status | Recruiting |
| Activation Date | |
| Eligibility Criteria |
|
| Exclusion Criteria | |
Groupe d'étude en oncologie du Québec